Partial protein-hydrolyzed infant formula decreased food sensitization but not allergic diseases in a prospective

Ho-Chang Kuo1, Chieh-An Liu, Chia-Yu Ou

  • 1Department of Pediatric Allergy and Immunology, Chang Gung Memorial Hospital-Kaohsiung Medical Center, Graduate Institute of Clinical Medical Science, Chang Gung University College of Medicine, Kaohsiung, Taiwan.

Insights

Feeding infants a hydrolyzed formula (HF) reduced milk protein sensitization but did not decrease overall allergic diseases by age 3. Cow's milk protein avoidance alone is insufficient for preventing allergies.

Area of Science:

  • Pediatric Allergy and Immunology
  • Nutritional Science
  • Dermatology

Background:

  • Early infant exposure to cow's milk protein is linked to increased allergy risk.
  • Investigating hydrolyzed formula (HF) for allergy prevention in high-risk infants.

Purpose of the Study:

  • To determine if hydrolyzed formula (HF) fed for the first 6 months reduces allergic diseases up to 36 months.
  • To assess the impact of HF on food and aeroallergen sensitization.

Main Methods:

  • Prospective study of 1,002 newborns at risk for atopy.
  • Infants received either HF or cow's milk formula (CM) for at least 6 months.
  • Monitoring for allergy sensitization and diseases at 6, 18, and 36 months.

Main Results:

  • Significantly lower milk protein sensitization in the HF group (12.7% vs. 23.4%) at 36 months.
  • No significant difference in aeroallergen sensitization between groups.
  • Allergic diseases correlated with aeroallergen sensitization, not feeding type or parental atopy.

Conclusions:

  • Hydrolyzed formula (HF) reduces milk protein sensitization but not overall allergic diseases by age 3.
  • Exclusive cow's milk protein avoidance in infancy is insufficient to prevent allergic diseases.
Abstract

Related Concept Videos

Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...